Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Smith

Showing results (31-40 of 97) with videos related to

Pageof 10
Sort By:
Lancet (London, England)|November 14, 2021
Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysisMilad Nazarzadeh, Zeinab Bidel, Dexter Canoy, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 6, 2022
Machine learning in sudden cardiac death risk prediction: a systematic reviewJoseph Barker, Xin Li, Sarah Khavandi, et al.
Cardiovascular Diabetology|June 20, 2026
Proteomics of multimorbidity progression across cardiometabolic diseases and cancer in a multinational cohortMichael J Stein, Vivian Viallon, Michael F Leitzmann, et al.
Elife|April 20, 2023
Common genetic variations in telomere length genes and lung cancer: a Mendelian randomisation study and its novel application in lung tumour transcriptomeRicardo Cortez Cardoso Penha, Karl Smith-Byrne, Joshua R Atkins, et al.
Cells|March 6, 2021
Genetically Raised Circulating Bilirubin Levels and Risk of Ten Cancers: A Mendelian Randomization StudyNazlisadat Seyed Khoei, Robert Carreras-Torres, Neil Murphy, et al.
International Journal of Cancer|November 30, 2020
Circulating insulin-like growth factor-I, total and free testosterone concentrations and prostate cancer risk in 200 000 men in UK BiobankEleanor L Watts, Georgina K Fensom, Karl Smith Byrne, et al.
JACC. Cardiooncology|May 14, 2025
Blood Pressure Lowering and Risk of Cancer: Individual Participant-Level Data Meta-Analysis and Mendelian Randomization StudiesMilad Nazarzadeh, Emma Copland, Karl Smith Byrne, et al.
British Journal of Cancer|December 20, 2025
A prospective investigation of early-onset colorectal cancer risk factors-pooled analysis of three large-scale European cohortsRuhina S Laskar, Neil Murphy, Pietro Ferrari, et al.
Nature Communications|November 23, 2023
Evaluation of circulating plasma proteins in breast cancer using Mendelian randomisationAnders Mälarstig, Felix Grassmann, Leo Dahl, et al.
Medrxiv : the Preprint Server for Health Sciences|March 27, 2026
Identifying Plasma Proteins Associated with Risk of Solid Cancers: A 25-Year Prospective Analysis of 4,712 Circulating Proteins in the ARIC StudyZiqiao Wang, Vernon Burk, Zhe Huang, et al.
Pageof 10

Showing results (31-40 of 97) with videos related to

Sort By:
Pageof 10
Lancet (London, England)|November 14, 2021
Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysisMilad Nazarzadeh, Zeinab Bidel, Dexter Canoy, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 6, 2022
Machine learning in sudden cardiac death risk prediction: a systematic reviewJoseph Barker, Xin Li, Sarah Khavandi, et al.
Cardiovascular Diabetology|June 20, 2026
Proteomics of multimorbidity progression across cardiometabolic diseases and cancer in a multinational cohortMichael J Stein, Vivian Viallon, Michael F Leitzmann, et al.
Elife|April 20, 2023
Common genetic variations in telomere length genes and lung cancer: a Mendelian randomisation study and its novel application in lung tumour transcriptomeRicardo Cortez Cardoso Penha, Karl Smith-Byrne, Joshua R Atkins, et al.
Cells|March 6, 2021
Genetically Raised Circulating Bilirubin Levels and Risk of Ten Cancers: A Mendelian Randomization StudyNazlisadat Seyed Khoei, Robert Carreras-Torres, Neil Murphy, et al.
International Journal of Cancer|November 30, 2020
Circulating insulin-like growth factor-I, total and free testosterone concentrations and prostate cancer risk in 200 000 men in UK BiobankEleanor L Watts, Georgina K Fensom, Karl Smith Byrne, et al.
JACC. Cardiooncology|May 14, 2025
Blood Pressure Lowering and Risk of Cancer: Individual Participant-Level Data Meta-Analysis and Mendelian Randomization StudiesMilad Nazarzadeh, Emma Copland, Karl Smith Byrne, et al.
British Journal of Cancer|December 20, 2025
A prospective investigation of early-onset colorectal cancer risk factors-pooled analysis of three large-scale European cohortsRuhina S Laskar, Neil Murphy, Pietro Ferrari, et al.
Nature Communications|November 23, 2023
Evaluation of circulating plasma proteins in breast cancer using Mendelian randomisationAnders Mälarstig, Felix Grassmann, Leo Dahl, et al.
Medrxiv : the Preprint Server for Health Sciences|March 27, 2026
Identifying Plasma Proteins Associated with Risk of Solid Cancers: A 25-Year Prospective Analysis of 4,712 Circulating Proteins in the ARIC StudyZiqiao Wang, Vernon Burk, Zhe Huang, et al.
Pageof 10